Deals In Depth: July 2018
Executive Summary
Merck & Co. signed a $1.66 billion deal to license Sutro Biopharma’s immune-modulating cytokine derivatives in oncology and autoimmune disease. Boston Scientific announced two acquisitions, Claret Medical in the embolic protection space, and Cryterion Medical, a cryoablation company. Biopharma and device financing slowed down in July.